The acute toxicity study of the leaves of Sphenocentrum jollyanum (SJ) showed no toxicity when administered up to 11g/kg body weight orally while intra-peritoneal (IP) administration produced dose dependent mortality with median acute toxicity (LD 50 ) of 1445.4 mg/kg. In sub-chronic study, the extract administered for a period of 120 days showed no mortality or morbidity. There was significant weight gain in both treated and control groups while gross examination of internal organs revealed no detectable inflammation. The blood glucose and total cholesterol levels demonstrated dose dependent decrease while high density lipoprotein cholesterol (HDLcholesterol) increased with dose. In the liver function test, there were no significant (p>0.05) changes in alanine amino transferase (ALT) and aspertate amino transferase (AST) in the extract treated animals. The renal function profile, serum creatinine and urea levels were not significantly altered compared to the control. In haematological evaluation, significant increase (p<0.05) in red blood cells (RBC), packed cell volume (PCV) and haemoglobin (Hb) were observed in the treated animals compared to the control while mean corpuscular (MCV), mean corpuscular haemoglobin (MCH), mean corpuscular haemoglobin concentration (MCHC) and white blood cells (WBC) showed no significant changes. The result therefore suggests that the leaves extract was potentially safe for consumption orally even at chronic administration.